Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CBUS
CBUS logo

CBUS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cibus Inc (CBUS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.980
1 Day change
8.79%
52 Week Range
4.190
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Cibus Inc (CBUS) is not a good buy for a beginner investor with a long-term horizon at this time. The company is undergoing financial challenges, as evidenced by declining revenue and negative earnings, and has recently priced a public offering that has led to significant negative sentiment. While there are potential catalysts in the future, such as regulatory changes in the EU and cost-cutting measures, the current financial and market conditions do not support a strong buy recommendation.

Technical Analysis

The technical indicators suggest a bearish trend. The MACD is negatively expanding, RSI is at 25.129 indicating oversold conditions, and moving averages are converging. The stock price is trading close to its S1 support level of 2.182, with significant resistance at 3.007.

Options Data

Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
7

Positive Catalysts

  • Jefferies raised the price target to $3 from $1.90, citing sufficient cash for operations through Q3 2026 and potential regulatory changes in the EU that could drive customer engagement.

Neutral/Negative Catalysts

  • The recent public offering priced at $2.15 per share led to a pre-market drop of over 20% and a regular market drop of 25.78%. Financial performance shows declining revenue (-12.79% YoY) and negative EPS (-32.18% YoY). No significant insider or hedge fund activity to indicate confidence in the stock.

Financial Performance

In Q4 2025, revenue dropped by 12.79% YoY to $1,057,000. Net income improved slightly but remains negative at -$31,286,000. EPS declined by 32.18% YoY to -0.59. Gross margin remained flat at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Jefferies maintains a Hold rating with a price target increase to $3, citing cost-cutting measures and sufficient cash for operations through Q3 2026. However, the stock's current challenges overshadow these potential positives.

Wall Street analysts forecast CBUS stock price to rise
3 Analyst Rating
Wall Street analysts forecast CBUS stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 1.820
sliders
Low
15
Averages
18.67
High
25
Current: 1.820
sliders
Low
15
Averages
18.67
High
25
Jefferies
Hold
maintain
$3
AI Analysis
2026-03-25
Reason
Jefferies
Price Target
$3
AI Analysis
2026-03-25
maintain
Hold
Reason
Jefferies raised the firm's price target on Cibus to $3 from $1.90 and keeps a Hold rating on the shares. With the capital raise in January and cost cutting measures, Cibus aims tot have ample cash for operating expenses and capex through at least 3Q26, the analyst tells investors in a research note. With EU genetic engineering regulations likely finalized in Q2, the firm expects a pickup in customer engagement in trait insertion, single-cell cloning, field trial efficiency solutions, and biofragrance production.
Canaccord
Austin Moeller
Buy
downgrade
$18
2025-05-12
Reason
Canaccord
Austin Moeller
Price Target
$18
2025-05-12
downgrade
Buy
Reason
Canaccord analyst Austin Moeller lowered the firm's price target on Cibus to $17.50 from $18 and keeps a Buy rating on the shares. The firm noted Cibus is not yet generating meaningful commercial revenues at this point in the company's lifecycle. However, through contract research on behalf of customers relating to collaborative agreements for products and traits, the company has consistently generated some quarterly revenue in advance of major trait commercializations. Cibus' nearest-term revenue-generation opportunity continues is its sustainable ingredients biofragrance product pipeline.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CBUS
Unlock Now

People Also Watch